Nuvation Bio Inc., a global oncology company, announced that its CEO David Hung and CFO Philippe Sauvage will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026. The event will be webcast live and archived for 90 days on Nuvation Bio's website. The company focuses on developing innovative cancer therapies, including drugs like taletrectinib and safusidenib. This appearance highlights Nuvation Bio's ongoing efforts to engage investors and share updates on its pipeline and strategy.
The Bill Gates Foundation has invested 63% of its stock portfolio in just three large-cap companies. This high concentration indicates a focused investment strategy, which could mean higher risk if those stocks underperform but also potential for sig...
Injective (INJ) surged 14.4% to $6.3, reaching a six-month high driven by increased speculative demand and short position liquidations totaling over $441k. The altcoin's market cap rose 12% to $628 million, supported by rising open interest and deriv...
Stellar (XLM) surged 38.94% to $0.2731, driven by growing interest in its blockchain technology focused on cross-border transactions and financial inclusion. Its market cap reached $9.15 billion, reflecting increased influence in the crypto market. O...
Kahn Swick & Foti, LLC is investigating Humana Inc. following the company's 2023 financial results, which revealed a higher benefits expense ratio and a significant drop in adjusted earnings per share (EPS) compared to prior forecasts. Humana reporte...
The Delhi High Court ruled that Google infringed on Hindware's trademark by allowing competitors to use 'Hindware' as a keyword in its AdWords platform, awarding Hindware ₹3 million in damages. The judgment challenges Google's claim of being a passiv...
